Leica Microsystems Stellaris Microscope System with Confocal
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NICHD
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98026R00098
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
Documents1
The National Institutes of Health (NIH), Office of the Director (OD), has issued a Sources Sought notice (Procurement Identifier: 75N98026R00098) to assess the availability and technical capability of qualified small businesses—including 8(a), small disadvantaged, woman-owned, service-disabled veteran-owned, and HUBZone small businesses—to provide a new Leica Microsystems Stellaris Microscope System with Confocal, or an equivalent system. This procurement is intended to support advanced imaging needs for NIH laboratories in Bethesda, Maryland, and is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a size standard of 1,000 employees. The Product Service Code is 6640.
The primary objective of this procurement is to acquire a state-of-the-art confocal microscope system that delivers enhanced sensitivity, resolution, and advanced imaging modalities essential for modern cellular and subcellular research. The new system will replace the existing Leica SP8 confocal microscope, which has served as a critical imaging resource for approximately 25 laboratories in the past year and an estimated 50 laboratories over its operational lifetime. The current SP8 system (Model: TCSSP8, Serial Number: 8100000924, acquired in 2015) will be offered as a trade-in, and vendors are encouraged to indicate their acceptance of trade-ins and provide an estimated trade-in value or credit structure in their capability statements.
The required system must be brand name or equal to the Leica Stellaris platform and must support advanced confocal imaging, three-dimensional STED (Stimulated Emission Depletion) super-resolution, fluorescence lifetime imaging (FLIM), and high-plex spectral multiplexing workflows (up to 15 colors). These capabilities are critical for supporting spatial-omics studies and complex multi-parameter imaging experiments.
Key technical requirements and salient characteristics include:
- Confocal excitation via a white light laser with a tunable excitation range of 440–790 nm, equipped with an AOBS system.
- Prism-based spectral detection with variable emission windows extending to 850 nm.
- Five Hybrid (HyD) detectors optimized for spectral detection across approximately 400–850 nm.
- 3D STED super-resolution capability with pulsed depletion at 775 nm and 589 nm.
- Integrated FLIM module for fluorescence lifetime measurements, super-resolution enhancement, and lifetime-based species separation.
- Pulse picker functionality to adjust the white light laser repetition rate for FLIM and related applications.
- Fast-switching between galvo and resonant scanning modes to accommodate both high-resolution and high-speed imaging.
- Motorized correction collar hardware and software support for existing Leica 100x oil and 93x glycerol objectives.
- Inclusion of a new Leica 86x water-immersion objective with correction collar, chromatically corrected across the full excitation range and optimized for STED depletion at 589 nm and 775 nm.
- High-plex spectral multiplexing capability for imaging 15 or more fluorescent colors per sample, with tools for panel planning and spectral unmixing.
Interested vendors must submit a detailed capability statement demonstrating their experience, skills, and ability to meet all specified requirements. Submissions should include descriptive literature, delivery timeframes, warranty information, and any other relevant details that substantiate the offer’s compliance with the stated specifications. Firms must also identify their business size and type in accordance with SBA set-aside requirements.
The place of performance for this procurement is Bethesda, Maryland, United States. The contracting entity is the National Institutes of Health, NICHD, under the Department of Health and Human Services. The primary point of contact for this notice is Tina Robinson, who can be reached at [email protected].
This notice is for information and planning purposes only and does not constitute a commitment by the Government. No reimbursement will be made for any costs associated with providing information in response to this notice. All capability statements must be submitted via email to [email protected], referencing solicitation number 75N98026R00098 in the subject line, by 5:00 pm Eastern Daylight Time on June 23, 2026. Any questions regarding this notice should also be directed to the same email address, with the solicitation number included in the subject line.
For further details and to access the official notice and any attachments, interested parties should refer to the SAM.gov opportunity at: https://sam.gov/opp/6735c54d19904aac9da8b7127da2dd00/view.